Format
Sort by
Items per page

Send to

Choose Destination

Links from Books

Items: 9

1.

Towards Gram-positive antivirulence drugs: new inhibitors of Streptococcus agalactiae Stk1.

Oxoby M, Moreau F, Durant L, Denis A, Genevard JM, Vongsouthi V, Escaich S, Gerusz V.

Bioorg Med Chem Lett. 2010 Jun 15;20(12):3486-90. doi: 10.1016/j.bmcl.2010.04.150.

2.

Reduced thrombin generation increases host susceptibility to group A streptococcal infection.

Sun H, Wang X, Degen JL, Ginsburg D.

Blood. 2009 Feb 5;113(6):1358-64. doi: 10.1182/blood-2008-07-170506.

3.

Antivirulence as a new antibacterial approach for chemotherapy.

Escaich S.

Curr Opin Chem Biol. 2008 Aug;12(4):400-8. doi: 10.1016/j.cbpa.2008.06.022. Review.

PMID:
18639647
4.

Virulence blockers as alternatives to antibiotics: type III secretion inhibitors against Gram-negative bacteria.

Keyser P, Elofsson M, Rosell S, Wolf-Watz H.

J Intern Med. 2008 Jul;264(1):17-29. doi: 10.1111/j.1365-2796.2008.01941.x.

5.

Pilicides-small molecules targeting bacterial virulence.

Aberg V, Almqvist F.

Org Biomol Chem. 2007 Jun 21;5(12):1827-34.

PMID:
17551629
6.

Plasminogen is a critical host pathogenicity factor for group A streptococcal infection.

Sun H, Ringdahl U, Homeister JW, Fay WP, Engleberg NC, Yang AY, Rozek LS, Wang X, Sjöbring U, Ginsburg D.

Science. 2004 Aug 27;305(5688):1283-6.

7.
8.

Identification of key gene products required for acquisition of plasmin-like enzymatic activity by group A streptococci.

Christner R, Li Z, Raeder R, Podbielski A, Boyle MD.

J Infect Dis. 1997 May;175(5):1115-20.

PMID:
9129074
9.

Streptococcal infections of skin and soft tissues.

Bisno AL, Stevens DL.

N Engl J Med. 1996 Jan 25;334(4):240-5. Review. No abstract available.

PMID:
8532002

Supplemental Content

Support Center